
zzso zzso may improve outcome after kidney zzso We performed a pilot study to assess feasibility and safety of zzso zzso in human zzso kidney zzso Twenty patients were zzso zzso outcome was rate of serious adverse zzso Secondary outcomes were zzso of zzso and zzso function at 3 zzso Data were compared to a historical control group zzso zzso zzso Furthermore, we performed a paired kidney analysis using the zzso kidney zzso zzso zzso zzso age and serum zzso were higher in the experimental group compared with historical zzso zzso zzso zzso zzso zzso years zzso zzso zzso and 79 zzso zzso zzso 64 zzso zzso zzso zzso zzso zzso could be applied all zzso One complication, a zzso zzso occurred related to zzso The experimental group experienced more zzso zzso zzso zzso zzso zzso zzso zzso zzso at month 3 was 166 zzso zzso zzso 159 zzso zzso zzso zzso zzso zzso kidney analysis showed no significant differences in zzso zzso zzso zzso P zzso zzso and serum zzso 199 zzso zzso zzso 184 zzso zzso zzso zzso zzso This is the first report of applying zzso in human kidney zzso Although zzso is feasible and appears to be safe, no benefit in terms of reduced zzso or better zzso function was observed zzso trial registry number zzso zzso 

